Clinical trial
Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal…
NCT00491855 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00491855 |
|---|---|
| Title | Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis |
| Official title | Phase I Trial of Intraperitoneal Oxaliplatin and Paclitaxel Plus Intravenous Paclitaxel and Bevacizumab in the Treatment of Advanced Peritoneal Carcinomatosis |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Peritoneal Cancer |
| Intervention type | Drug |
| Interventions | Bevacizumab, Oxaliplatin, Paclitaxel |
| Enrollment | 3 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Jun 26, 2007 |
| Last update posted | Jan 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: